DiaMedica Therapeutics reported earnings of -$ 0.21 per DMAC share on Nov 12, 2026, beating analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 0.21 |
| Earnings Per Share (Surprise) | -$ 0.21 ($ 0.00) |
| Last Year's EPS | -$ 0.18 |
| EPS YoY Change |
Out of the last 87 earnings reporting periods, DiaMedica Therapeutics beat analysts’ expectations 16 times and fell short of expectations 12 time(s). DiaMedica Therapeutics reported earnings per share of -$ 0.21 in the last report falling to reach an estimated EPS of -$ 0.21 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.21 | -$ 0.21 | -$ 0.17 | |
| Aug 10, 2026 | -$ 0.20 | -$ 0.19 | -$ 0.18 | |
| May 6, 2026 | -$ 0.17 | -$ 0.19 | -$ 0.18 | |
| Mar 30, 2026 | -$ 0.17 | -$ 0.17 | -$ 0.18 | |
| Nov 12, 2025 | -$ 0.15 | -$ 0.17 | -$ 0.15 | |
| Aug 12, 2025 | -$ 0.18 | -$ 0.18 | -$ 0.13 | |
| May 13, 2025 | -$ 0.18 | -$ 0.18 | -$ 0.14 | |
| Mar 17, 2025 | -$ 0.17 | -$ 0.18 | -$ 0.14 | |
| Nov 13, 2024 | -$ 0.15 | -$ 0.15 | -$ 0.12 | |
| Aug 7, 2024 | -$ 0.16 | -$ 0.13 | -$ 0.16 | |
| May 8, 2024 | -$ 0.16 | -$ 0.14 | -$ 0.20 | |
| Mar 19, 2024 | -$ 0.14 | -$ 0.14 | -$ 0.14 | |
| Nov 13, 2023 | -$ 0.14 | -$ 0.12 | -$ 0.12 | |
| Aug 14, 2023 | -$ 0.22 | -$ 0.16 | -$ 0.13 | |
| May 15, 2023 | -$ 0.16 | -$ 0.20 | -$ 0.13 | |
| Mar 28, 2023 | -$ 0.14 | -$ 0.14 | -$ 0.10 | |
| Nov 9, 2022 | -$ 0.13 | -$ 0.12 | -$ 0.18 | |
| Aug 10, 2022 | -$ 0.16 | -$ 0.13 | -$ 0.17 | |
| May 4, 2022 | -$ 0.20 | -$ 0.13 | -$ 0.19 | |
| Mar 14, 2022 | -$ 0.16 | -$ 0.10 | -$ 0.23 |
DiaMedica Therapeutics’s stock was trading at $ 9.66 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, DMAC’s price decreased to $ 8.79 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.21 | $ 9.66 | $ 8.79 | |
| Aug 10, 2026 | -$ 0.19 | $ 6.75 | $ 6.87 | |
| May 6, 2026 | -$ 0.19 | $ 6.25 | $ 6.53 | |
| Mar 30, 2026 | -$ 0.17 | $ 6.79 | $ 6.77 | |
| Nov 12, 2025 | -$ 0.17 | $ 6.39 | $ 5.42 | |
| Aug 12, 2025 | -$ 0.18 | $ 4.58 | $ 6.00 | |
| May 13, 2025 | -$ 0.18 | $ 3.83 | $ 4.00 | |
| Mar 17, 2025 | -$ 0.18 | $ 5.77 | $ 5.21 | |
| Nov 13, 2024 | -$ 0.15 | $ 4.31 | $ 4.12 | |
| Aug 7, 2024 | -$ 0.13 | $ 3.35 | $ 3.35 | |
| May 8, 2024 | -$ 0.14 | $ 3.66 | $ 3.25 | |
| Mar 19, 2024 | -$ 0.14 | $ 2.85 | $ 2.77 | |
| Nov 13, 2023 | -$ 0.12 | $ 2.36 | $ 2.50 | |
| Aug 14, 2023 | -$ 0.16 | $ 2.80 | $ 2.97 | |
| May 15, 2023 | -$ 0.20 | $ 1.62 | $ 1.77 | |
| Mar 28, 2023 | -$ 0.14 | $ 1.56 | $ 1.47 | |
| Nov 9, 2022 | -$ 0.12 | $ 1.24 | $ 1.21 | |
| Aug 10, 2022 | -$ 0.13 | $ 1.68 | $ 1.90 | |
| May 4, 2022 | -$ 0.13 | $ 2.62 | $ 2.55 | |
| Mar 14, 2022 | -$ 0.10 | $ 2.54 | $ 2.30 |
DiaMedica Therapeutics released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
DiaMedica Therapeutics missed analysts’ expectations during the last earnings period by
